• Phosphatase Inhibitor Cocktail 3: Practical Guide

  2026-09-04

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) helps limit dephosphorylation during extraction of animal tissues and cultured cells, supporting protein phosphorylation preservation for phosphoprotein analysis. It is intended for phosphorylation-sensitive sample preparation and downstream assays, not for measuring native phosphatase activity unless inhibitor carryover is specifically excluded or validated.

• ECL Chemiluminescent Substrate Detection Kit

  2026-09-04

  Improve western blot chemiluminescent detection when target proteins are scarce, antibody is limited, or longer imaging windows are valuable. This hypersensitive HRP substrate supports low-picogram immunoblotting on nitrocellulose and PVDF membranes with reduced background and a working reagent that remains usable for 24 hours.

• BML-277 and the Next Era of Chk2 Research

  2026-09-03

  BML-277 offers a precise way to interrogate Chk2-dependent DNA damage signaling, from T-cell radioprotection to emerging nuclear cGAS biology. This thought-leadership article connects biochemical potency with translational assay design while defining the evidence boundaries for applying Chk2 inhibition to genome stability and cancer research.

• Structure-Guided Proteomimetics Target SARS-CoV-2

  2026-09-03

  The reference study presents a structure-guided strategy for converting two hACE2 recognition elements into constrained proteomimetics that engage the SARS-CoV-2 Spike receptor-binding domain. Its lead compound, proteomimetic 28, disrupted the S-RBD/hACE2 interaction, reduced pseudovirus entry, and showed epithelial stability and low permeability that support further investigation of intranasal antiviral delivery.

• Iron Stress Reprograms Enterocyte Metabolism

  2026-09-02

  Navazesh and Ji show that both iron deficiency and iron excess reorganize enterocyte gene regulation and metabolism, but through distinct patterns involving proliferation, glycolysis, cholesterol synthesis, and antioxidant status. The IPEC-J2 model provides a useful framework for connecting iron availability with intestinal inflammation and for designing iron-depletion, excess, and repletion experiments.

• 0.4% Trypan Blue Solution: Practical Cell Viability

  2026-09-02

  0.4% Trypan Blue Solution is an azo dye for cell staining that supports rapid cell viability measurement, live/dead cell discrimination, and cell counting in research workflows. It is intended for cultured-cell and cytotoxicity applications only, not for diagnostic, therapeutic, or other medical use.

• Ranolazine: A Compartment-Aware Research Guide

  2026-09-01

  Ranolazine is an anti-ischemic agent with linked electrophysiological and metabolic effects. This guide presents a compartment-aware framework for cardiac ischemia research and explains how findings on HBsAg–TBK1 signaling can improve assay interpretation without overstating antiviral relevance.

• ROS-Responsive Lipids for Selective mRNA Delivery

  2026-09-01

  Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids and identified BAmP-TK-12 as a preferential mRNA carrier for tumor cells. The study links lipid pKa and ROS-triggered degradation to delivery performance and demonstrates that DUF5-encoding mRNA can suppress mutant RAS signaling in cellular and animal tumor models.

• Urine Nanosensor for Early Atherosclerosis Detection

  2026-08-31

  Wu and colleagues developed a carbon quantum dot nanosensor that converts atherosclerosis-associated proteolytic activity into a urinary fluorescence signal. In early-stage mouse models, the assay distinguished atherosclerotic animals from healthy controls, supporting a minimally invasive strategy that may complement—not replace—established imaging and molecular analyses.

• CTCF Maintains Centromere Function in Mitosis

  2026-08-31

  The reference study uses rapid, inducible CTCF degradation to show that CTCF preserves centromere mechanics, metaphase organization, mitotic fidelity, and post-mitotic nuclear shape. Its key mechanistic insight is that CTCF loss disrupts centromere architecture without substantially preventing CENP-E recruitment, distinguishing a structural centromere defect from a primary chromosome-congression defect.

• L-NAME Hydrochloride: Applied NOS Workflows

  2026-08-30

  L-NAME Hydrochloride enables controlled inhibition of nitric oxide synthase across vascular, cellular, and inflammatory assays. This workflow-focused guide shows how to separate NO-dependent effects from NF-κB, prostaglandin, and receptor-linked mechanisms while improving dose selection, controls, and troubleshooting.

• Z-VEID-FMK for Host–Virus Apoptosis Mapping

  2026-08-29

  Z-VEID-FMK is a cell-permeable caspase-6 inhibitor for testing whether caspase-6 controls host-protein turnover during infection. This article translates the SVA–DDX23 study into a rigorous assay strategy that separates target engagement, apoptosis, and antiviral phenotype.

• Lamotrigine in BBB Permeability Workflows

  2026-08-28

  Use Lamotrigine as a mechanistically informative probe in high-throughput blood-brain barrier, transporter, and lysosomal-trapping workflows. This guide translates a validated LLC-PK1-MOCK/MDR1 model into practical assay decisions while separating BBB permeability evidence from sodium-channel, serotonin, and cardiac follow-up studies.

• Thioguanine Workflows for Translational Research

  2026-08-28

  Thioguanine, also called 6-thioguanine, supports practical cancer, epigenetic, and antiviral assay development when solubility, exposure time, and formulation are controlled. This guide translates published nanoparticle findings into reproducible workflows, assay-selection strategies, and troubleshooting decisions.

• ECL Chemiluminescent Substrate for Low-Abundance Blots

  2026-08-27

  The ECL Chemiluminescent Substrate Detection Kit supports sensitive western blot analysis of low-abundance proteins. This article connects its HRP-based detection chemistry to mechanistic validation of puerarin research in type 2 diabetes, emphasizing assay design, controls, and interpretation rather than product specifications alone.

8318 records 1/555 page Next 12345 下5页 Last page